INR 17.37
(-2.74%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 291.17 Million INR | -52.58% |
2022 | 434.66 Million INR | 1.94% |
2021 | 426.38 Million INR | -25.51% |
2020 | 572.44 Million INR | 2.25% |
2019 | 559.82 Million INR | 15.6% |
2018 | 484.27 Million INR | 5.35% |
2017 | 459.67 Million INR | 57.42% |
2016 | 292 Million INR | 0.0% |
2015 | - INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 53.53 Million INR | -21.43% |
2023 Q4 | 68.12 Million INR | 65.15% |
2023 FY | 206.09 Million INR | -52.58% |
2023 Q1 | 88.5 Million INR | -9.67% |
2023 Q3 | 41.25 Million INR | -56.26% |
2023 Q2 | 94.31 Million INR | 6.56% |
2022 Q3 | 117.2 Million INR | 4.72% |
2022 Q1 | 107.55 Million INR | 31.49% |
2022 FY | 434.66 Million INR | 1.94% |
2022 Q4 | 97.98 Million INR | -16.4% |
2022 Q2 | 111.92 Million INR | 4.07% |
2021 Q1 | 132.09 Million INR | 10.45% |
2021 FY | 426.38 Million INR | -25.51% |
2021 Q4 | 81.79 Million INR | -1.87% |
2021 Q3 | 83.35 Million INR | -35.46% |
2021 Q2 | 129.14 Million INR | -2.24% |
2020 Q3 | 165.57 Million INR | 7.84% |
2020 Q4 | 119.59 Million INR | -27.77% |
2020 FY | 572.44 Million INR | 2.25% |
2020 Q1 | 133.75 Million INR | -22.94% |
2020 Q2 | 153.52 Million INR | 14.78% |
2019 FY | 559.82 Million INR | 15.6% |
2019 Q4 | 173.56 Million INR | 26.22% |
2019 Q3 | 137.51 Million INR | 3.88% |
2019 Q2 | 132.37 Million INR | 13.76% |
2019 Q1 | 116.37 Million INR | -6.49% |
2018 Q3 | 124.95 Million INR | 2.86% |
2018 Q2 | 121.48 Million INR | 7.13% |
2018 Q1 | 113.39 Million INR | -18.49% |
2018 FY | 484.27 Million INR | 5.35% |
2018 Q4 | 124.44 Million INR | -0.41% |
2017 FY | 459.67 Million INR | 57.42% |
2017 Q1 | 89.28 Million INR | 0.0% |
2017 Q4 | 139.12 Million INR | 25.94% |
2017 Q2 | 135.23 Million INR | 51.47% |
2017 Q3 | 110.47 Million INR | -18.31% |
2016 Q1 | 64.93 Million INR | 0.0% |
2016 FY | 292 Million INR | 0.0% |
2015 FY | - INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 98.165% |
Hester Biosciences Limited | 908.84 Million INR | 67.962% |
Aarti Drugs Limited | 1.16 Billion INR | 75.06% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 90.529% |
Albert David Limited | 1.02 Billion INR | 71.625% |
Alembic Limited | 872.45 Million INR | 66.626% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.113% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 36.088% |
Bajaj HealthCare Limited | 985.34 Million INR | 70.45% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -4169.413% |
Brooks Laboratories Limited | 51.18 Million INR | -468.921% |
Eris Lifesciences Limited | 4.94 Billion INR | 94.109% |
FDC Limited | 3.49 Billion INR | 91.68% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 97.499% |
Gufic Biosciences Limited | 1.18 Billion INR | 75.461% |
Hikal Limited | 4.46 Billion INR | 93.477% |
Ind-Swift Limited | 946.56 Million INR | 69.239% |
Innova Captab Limited | 931.03 Million INR | 68.726% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 86.771% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 33.605% |
Jubilant Pharmova Limited | 14.45 Billion INR | 97.986% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 72.894% |
Lupin Limited | 125.09 Billion INR | 99.767% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -79.484% |
Medico Remedies Limited | 59.67 Million INR | -387.933% |
Morepen Laboratories Limited | 1.98 Billion INR | 85.349% |
Nectar Lifesciences Limited | 932.7 Million INR | 68.782% |
Orchid Pharma Limited | 800.77 Million INR | 63.638% |
Procter & Gamble Health Limited | 2.99 Billion INR | 90.279% |
RPG Life Sciences Limited | 1.63 Billion INR | 82.197% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 29.4% |
Sigachi Industries Limited | 579.88 Million INR | 49.788% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 88.6% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 79.243% |
Themis Medicare Limited | 1.12 Billion INR | 74.136% |
Unichem Laboratories Limited | 6.72 Billion INR | 95.671% |
Vaishali Pharma Limited | 84.02 Million INR | -246.516% |
Wanbury Limited | 978.96 Million INR | 70.257% |
Windlas Biotech Limited | 1 Billion INR | 71.071% |
ZIM Laboratories Limited | 1.01 Billion INR | 71.258% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 86.292% |
Ipca Laboratories Limited | 18.98 Billion INR | 98.467% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.811% |
Venus Remedies Limited | 1.91 Billion INR | 84.805% |
Sakar Healthcare Limited | 204.07 Million INR | -42.677% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.477% |
Divi's Laboratories Limited | 14.17 Billion INR | 97.945% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 88.228% |
Mankind Pharma Limited | 29.27 Billion INR | 99.005% |
Sequent Scientific Limited | 2.9 Billion INR | 89.966% |
Laurus Labs Limited | 11.9 Billion INR | 97.555% |
Neuland Laboratories Limited | 2.92 Billion INR | 90.061% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 98.032% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.38% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.767% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 86.095% |
Wockhardt Limited | 8.48 Billion INR | 96.566% |
Bal Pharma Limited | 555.62 Million INR | 47.595% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.696% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 79.484% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -399.543% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 86.61% |
Shilpa Medicare Limited | 3.33 Billion INR | 91.267% |
Valiant Laboratories Limited | 138.02 Million INR | -110.951% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.044% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -1948.646% |
Granules India Limited | 10.31 Billion INR | 97.177% |
Medicamen Biotech Limited | 335.16 Million INR | 13.126% |
Syncom Formulations (India) Limited | 345.63 Million INR | 15.756% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.543% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 98.641% |
NATCO Pharma Limited | 10.05 Billion INR | 97.105% |
Suven Life Sciences Limited | 109.75 Million INR | -165.307% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -530.848% |
Strides Pharma Science Limited | 9.16 Billion INR | 96.822% |
Indoco Remedies Limited | 12.06 Billion INR | 97.586% |
Alpa Laboratories Limited | 127.38 Million INR | -128.587% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 90.536% |